AI Terminal
NUFORMIX PLC
Director's Dealing • Sep 16, 2021
4941_dirs_2021-09-16_0cef621d-0f29-40a0-be6e-619a5e68abc1.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0484M
Nuformix PLC
16 September 2021
The following amendments have been made to the 'Director/PDMR Shareholding' announcement released on 16/09/2021 at 12:47 p.m. under RNS No 0420M.
The price paid was 1.35 pence, not 0.0135 pence.
All other details remain unchanged.
16 September 2021
Nuformix plc
("Nuformix" or the "the Company")
Director/PDMR Shareholding
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that today the Company received notice that Dr Alastair Riddell purchased 350,000 ordinary shares of 0.1 pence each ("Ordinary Shares") at a price of 1.35 pence per share on 16 September 2021.
- Ends -
Enquiries:
| Nuformix plc | +44 (0) 1223 627 222 |
| Dr Anne Brindley, CEO | |
| Allenby Capital Limited | +44 (0) 20 3328 5656 |
| Nick Athanas / George Payne (Corporate Finance) | |
| Stefano Aquilino / Matt Butlin (Sales & Corporate Broking) | |
| Walbrook PR Anna Dunphy / Paul McManus |
+44 (0) 20 7933 8780 [email protected] |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Dr Alastair Riddell
2
Reason for the notification
a)
Position/status
PDMR - Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Nuformix plc
b)
LEI
2138003XG3H3I2J3BJ24
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of nominal value 0.1 pence each
GB00BYW79Y38
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 1.35p | 350,000 |
d)
Aggregated information
- Aggregated volume
- Price
- Total
350,000
1.35p
£4,725.00
e)
Date of the transaction
16 September 2021
f)
Place of the transaction
London Stock Exchange, Main Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHDKABDNBKDDCD